乳腺癌相关抗原在乳腺癌辅助诊断中的应用

目的 探讨乳腺癌相关抗原CA15-3动态检测对乳腺癌的早期诊断价值.方法 运用SEROZYME系统检测了疑有乳房疾患和妇女健康普查的妇女512人外周血CA15-3数值,并对CA15-3值高于27.4 IU/mL的患者1～3月后再次复查CA15-3.结果 CA15-3动态增高组PVPT为85.7%.CA15-3相近和降低组6例,病理检查证实为乳腺癌1例,阳性预测值(PVPT)为16.7%.结论 CA15-3动态检测对乳腺癌早期诊断有重要价值,尤其是CA15-3高于40IU/ml的动态升高组在乳腺癌早期诊断中具有不可替代的预测作用.

The breast cancer relevance antigen assists application in diagnosing in breast cancer

Objective The goal discusses the CA15 - 3 dynamic examinations to the breast cancer early diagnosis value. Methods The methods using the SEROZYME system has examined the women doubted has the breast illness and the woman healthy general survey woman 512 person of peripheral blood CA15 - 3 values, and was higher than 27. d. IU/ml after the CA15 - 3 values the patient 1 -3 month to reexamine CA15 once more - 3. Results CA15 - 3 dynamic advances group PVPT is 85.7%. CA15 - 3 is close and reduces the group 6 examples, the pathology inspection card actually breast cancer 1 example, PVPT is 16.7%. Conclusion CA15 - 3 dynamic examinations has the important value to the breast cancer early time diagnosis, CA15 - 3 is higher than 40 IU/ml the tendency to elevate the group in particular the forecast function which has in the breast cancer early time diagnosis cannot be substituted.